Get my own profile
Public access
View all5 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Jane KnöchelUniversity of Potsdam, AstraZenecaVerified email at uni-potsdam.de
- Michael AshtonGothenburgVerified email at gu.se
- Youwei BiUS FDAVerified email at fda.hhs.gov
- Hae-chang RimKorea UniversityVerified email at nlp.korea.ac.kr
- Kenta YoshidaGenentechVerified email at gene.com
- Bengt HamrénCVMD QCP Lead, AstraZenecaVerified email at waehlby.com
- Aleksandra GaletinProfessor of Translational Pharmacokinetics, University of Manchester, UKVerified email at manchester.ac.uk
- gustafsson llprofessor i klinisk farmakologi, Karolinska Institutet StockholmVerified email at ki.se
- Eleni AklilluProfessor of Tropical Pharmacology, Karolinska InstitutetVerified email at ki.se
- Paul WaakoProfessor of Pharmacology and Therapuetics Busitema UniversityVerified email at adm.busitema.ac.ug
- Magnus GisslénVerified email at infect.gu.se
- Eva Hurt-camejoChief Scientist, R&D BiophaPharmaceuticals, AstraZeneca. Adj.Professor, Karolisnka InstituteVerified email at astrazeneca.com
- Oskar CleweBoehringer Ingelheim Pharma GmbH & Co. KGVerified email at boehringer-ingelheim.com
- Jacob LeanderClinical Pharmacology & Pharmacometrics, AstraZeneca R&DVerified email at astrazeneca.com
- Jennifer SchumiStatistics TA Head, Immunology/Biosimilars, Teva PharmaceuticalsVerified email at tevapharm.com
- Anshu MaratheDirector, NovartisVerified email at novartis.com
- Peter GennemarkResearcher at AstraZenecaVerified email at astrazeneca.com
- Ulrika SH SimonssonUppsala UniversityVerified email at farmbio.uu.se
- Magnus ÅstrandSenior Pharmacometrician, AstraZeneca R&DVerified email at astrazeneca.com
- Ivan AzarovM&S DecisionsVerified email at msdecisions.ru